ARES TRADING. If ARES TRADING fails to exercise its Intrexon Program Option under Section 4.5(e), ARES TRADING shall not directly or indirectly, clinically develop or commercialize any Chimeric Antigen Receptor T-Cell Product against such Out-of-Scope Target under this Agreement.
Appears in 4 contracts
Samples: License and Collaboration Agreement, License and Collaboration Agreement, License and Collaboration Agreement (Ziopharm Oncology Inc)
